Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jeffrey Swigris

Concepts (372)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Idiopathic Pulmonary Fibrosis
67
2025
691
11.780
 Why?
Lung Diseases, Interstitial
62
2026
660
10.690
 Why?
Quality of Life
47
2025
3185
5.990
 Why?
Dyspnea
28
2025
251
5.780
 Why?
Pulmonary Fibrosis
26
2025
395
5.490
 Why?
Cough
10
2024
124
3.570
 Why?
Oxygen Inhalation Therapy
13
2021
182
3.320
 Why?
Surveys and Questionnaires
38
2025
6048
2.860
 Why?
Vital Capacity
33
2025
290
2.850
 Why?
Connective Tissue Diseases
13
2019
84
2.270
 Why?
Alveolitis, Extrinsic Allergic
6
2024
93
1.850
 Why?
Lymphangioleiomyomatosis
6
2024
36
1.730
 Why?
Arthritis, Rheumatoid
12
2024
1169
1.720
 Why?
Pyridones
12
2023
199
1.660
 Why?
Patient Reported Outcome Measures
7
2024
488
1.510
 Why?
Anti-Inflammatory Agents, Non-Steroidal
11
2021
338
1.480
 Why?
Patient Outcome Assessment
3
2021
134
1.400
 Why?
Sarcoidosis
5
2021
160
1.350
 Why?
Severity of Illness Index
20
2025
2925
1.350
 Why?
Indoles
6
2024
501
1.350
 Why?
Humans
166
2026
144759
1.270
 Why?
Aged
70
2025
25913
1.210
 Why?
Pulmonary Medicine
3
2022
79
1.210
 Why?
Lung
21
2024
4109
1.210
 Why?
Middle Aged
82
2025
35875
1.200
 Why?
Fatigue
9
2024
366
1.160
 Why?
Walking
7
2013
545
1.100
 Why?
Respiratory Function Tests
19
2025
547
1.090
 Why?
Psychometrics
10
2022
734
0.990
 Why?
Oxygen
7
2023
995
0.990
 Why?
Patients
3
2018
180
0.970
 Why?
Tomography, X-Ray Computed
20
2025
2730
0.950
 Why?
Male
91
2025
72315
0.940
 Why?
Hypertension, Pulmonary
6
2023
1980
0.930
 Why?
Exercise Test
9
2024
634
0.910
 Why?
Female
94
2025
78271
0.910
 Why?
Health Care Costs
3
2018
427
0.910
 Why?
Research Design
5
2016
1135
0.900
 Why?
Health Status Indicators
4
2014
166
0.900
 Why?
Patient-Centered Care
2
2021
544
0.860
 Why?
Activities of Daily Living
6
2022
441
0.850
 Why?
Disease Progression
20
2025
2847
0.840
 Why?
Reproducibility of Results
18
2024
3409
0.820
 Why?
Exercise Tolerance
4
2020
283
0.790
 Why?
Mycophenolic Acid
4
2016
120
0.740
 Why?
Forced Expiratory Volume
12
2023
449
0.720
 Why?
Idiopathic Interstitial Pneumonias
7
2026
44
0.690
 Why?
Organizational Objectives
1
2021
66
0.680
 Why?
Internet
2
2016
699
0.670
 Why?
Autoimmune Diseases
5
2026
463
0.670
 Why?
Nursing Research
1
2021
53
0.660
 Why?
Patient Satisfaction
3
2021
704
0.660
 Why?
Caregivers
4
2019
1049
0.660
 Why?
Pulmonary Emphysema
2
2024
275
0.630
 Why?
Lactic Acid
1
2022
302
0.630
 Why?
Rhinitis, Allergic
1
2020
42
0.610
 Why?
Undifferentiated Connective Tissue Diseases
1
2019
1
0.600
 Why?
Chronic Disease
5
2022
1813
0.600
 Why?
Symptom Assessment
1
2020
137
0.600
 Why?
Pulmonary Disease, Chronic Obstructive
4
2022
920
0.580
 Why?
Fatty Acids
1
2022
450
0.570
 Why?
Emphysema
1
2018
100
0.530
 Why?
Patient Education as Topic
3
2019
780
0.510
 Why?
Particulate Matter
1
2020
347
0.500
 Why?
Needs Assessment
2
2019
404
0.500
 Why?
Longitudinal Studies
9
2020
2947
0.490
 Why?
Lung Diseases
3
2015
787
0.490
 Why?
Pulmonary Diffusing Capacity
7
2019
78
0.480
 Why?
Aged, 80 and over
19
2021
8265
0.480
 Why?
Heart Rate
2
2011
855
0.470
 Why?
Immunosuppressive Agents
4
2016
846
0.460
 Why?
Qualitative Research
4
2017
1671
0.460
 Why?
Lung Transplantation
1
2019
338
0.460
 Why?
Prognosis
16
2026
4282
0.460
 Why?
Information Seeking Behavior
1
2016
38
0.450
 Why?
United States
25
2024
15966
0.450
 Why?
Treatment Outcome
20
2023
11679
0.450
 Why?
Myositis
4
2025
57
0.450
 Why?
Gastroesophageal Reflux
2
2021
236
0.440
 Why?
Air Pollutants
1
2020
438
0.440
 Why?
Exercise
4
2022
2201
0.440
 Why?
Adult
39
2024
40449
0.440
 Why?
Narration
1
2016
75
0.440
 Why?
Double-Blind Method
10
2024
2029
0.430
 Why?
Ambulatory Care
2
2018
600
0.430
 Why?
Mental Health
2
2020
790
0.420
 Why?
Kaplan-Meier Estimate
8
2018
965
0.410
 Why?
Retrospective Studies
27
2025
17066
0.410
 Why?
Autoantibodies
6
2023
1501
0.400
 Why?
Autoimmunity
2
2019
926
0.400
 Why?
Telemedicine
1
2023
945
0.400
 Why?
Biomedical Research
2
2018
710
0.400
 Why?
Antibodies, Monoclonal
1
2021
1519
0.400
 Why?
Antitussive Agents
1
2013
7
0.390
 Why?
Thalidomide
1
2013
43
0.380
 Why?
Bronchiolitis Obliterans
1
2013
66
0.380
 Why?
Social Media
1
2016
171
0.380
 Why?
Lung Neoplasms
4
2024
2637
0.370
 Why?
Physicians
2
2019
939
0.370
 Why?
Social Support
2
2019
652
0.370
 Why?
Motivation
1
2017
610
0.370
 Why?
Survival Rate
7
2019
2089
0.370
 Why?
Bronchial Diseases
1
2012
38
0.360
 Why?
Patient Participation
1
2015
431
0.350
 Why?
Follow-Up Studies
9
2018
5408
0.340
 Why?
Quality Indicators, Health Care
1
2014
335
0.330
 Why?
Scleroderma, Systemic
4
2019
123
0.330
 Why?
Oxygen Consumption
3
2022
724
0.330
 Why?
Health Knowledge, Attitudes, Practice
2
2018
1414
0.320
 Why?
Multivariate Analysis
5
2017
1539
0.320
 Why?
Peptides, Cyclic
1
2012
275
0.320
 Why?
Health Status
5
2019
836
0.320
 Why?
Asthma
2
2020
1767
0.310
 Why?
Motor Activity
1
2014
721
0.310
 Why?
Protein Kinase Inhibitors
3
2021
969
0.310
 Why?
Endothelins
1
2010
63
0.310
 Why?
Hospitalization
3
2017
2433
0.300
 Why?
Cause of Death
6
2019
471
0.290
 Why?
Diagnosis, Differential
7
2019
1489
0.290
 Why?
Pulmonologists
2
2019
14
0.290
 Why?
Pulmonary Embolism
1
2011
244
0.280
 Why?
Cohort Studies
8
2025
5960
0.280
 Why?
Proportional Hazards Models
4
2019
1325
0.280
 Why?
TRPP Cation Channels
1
2009
74
0.280
 Why?
Amino Acyl-tRNA Synthetases
3
2016
32
0.280
 Why?
Endothelin-1
1
2010
184
0.280
 Why?
Polycystic Kidney Diseases
1
2009
71
0.270
 Why?
Randomized Controlled Trials as Topic
6
2021
1720
0.270
 Why?
Registries
4
2025
2385
0.270
 Why?
Sleep Apnea, Obstructive
1
2012
300
0.260
 Why?
Prospective Studies
9
2021
7990
0.260
 Why?
Sirolimus
2
2023
281
0.260
 Why?
Vascular Endothelial Growth Factor D
3
2023
13
0.250
 Why?
Bronchoalveolar Lavage Fluid
2
2025
636
0.250
 Why?
Biopsy
7
2016
1075
0.250
 Why?
Sex Distribution
3
2012
386
0.240
 Why?
Tumor Suppressor Proteins
1
2009
321
0.240
 Why?
Home Care Services
2
2020
280
0.240
 Why?
Exercise Therapy
3
2024
473
0.240
 Why?
Palliative Care
3
2019
1002
0.230
 Why?
Prevalence
5
2018
2834
0.230
 Why?
Mortality
4
2019
375
0.230
 Why?
Cost of Illness
3
2018
321
0.230
 Why?
Patient Advocacy
2
2024
73
0.230
 Why?
Lupus Erythematosus, Systemic
1
2008
239
0.220
 Why?
Radiographic Image Interpretation, Computer-Assisted
1
2025
121
0.220
 Why?
Quality Improvement
1
2014
1289
0.220
 Why?
Fibrosis
2
2024
548
0.210
 Why?
Minimal Clinically Important Difference
2
2021
30
0.200
 Why?
Thrombosis
1
2008
393
0.200
 Why?
Age Distribution
3
2019
403
0.200
 Why?
Time Factors
7
2019
7173
0.190
 Why?
Databases, Factual
3
2019
1486
0.190
 Why?
Evidence-Based Medicine
2
2020
732
0.190
 Why?
Delphi Technique
1
2024
329
0.180
 Why?
Respiratory Therapy
2
2019
25
0.180
 Why?
Sex Factors
6
2019
2112
0.180
 Why?
Environmental Exposure
2
2020
588
0.180
 Why?
Receptors, Lysophosphatidic Acid
1
2021
40
0.170
 Why?
Patient Care Management
1
2021
56
0.170
 Why?
Incidence
3
2018
2879
0.160
 Why?
Analysis of Variance
3
2015
1306
0.160
 Why?
Linear Models
3
2019
854
0.160
 Why?
Pain Measurement
1
2022
552
0.160
 Why?
Survival Analysis
3
2017
1382
0.160
 Why?
Interleukin-13
1
2021
144
0.160
 Why?
Antibodies, Antinuclear
4
2016
62
0.160
 Why?
Logistic Models
4
2019
2117
0.160
 Why?
Focus Groups
3
2016
573
0.150
 Why?
Walk Test
2
2017
80
0.150
 Why?
Risk Factors
8
2021
10779
0.150
 Why?
Sensitivity and Specificity
3
2015
1985
0.150
 Why?
Chi-Square Distribution
2
2011
529
0.150
 Why?
General Practitioners
1
2019
26
0.140
 Why?
Allied Health Personnel
1
2019
55
0.140
 Why?
Insurance Claim Review
1
2018
83
0.140
 Why?
Immunoglobulin A
1
2019
214
0.140
 Why?
Terminal Care
2
2019
279
0.140
 Why?
Lipid Metabolism
1
2022
527
0.140
 Why?
Oxidation-Reduction
1
2022
1087
0.130
 Why?
Accelerometry
2
2019
119
0.130
 Why?
Anxiety
3
2019
1109
0.130
 Why?
Attitude to Health
2
2014
436
0.130
 Why?
Physician Assistants
1
2019
102
0.130
 Why?
Weight-Bearing
1
2018
181
0.130
 Why?
Cellular Senescence
1
2019
226
0.130
 Why?
Allergens
1
2020
384
0.120
 Why?
Inflammation
2
2025
2878
0.120
 Why?
Cross-Sectional Studies
4
2019
5868
0.120
 Why?
Germany
1
2017
138
0.120
 Why?
Nurse Practitioners
1
2019
140
0.120
 Why?
Common Variable Immunodeficiency
1
2016
26
0.120
 Why?
Nurses
1
2019
178
0.120
 Why?
Host-Pathogen Interactions
1
2019
371
0.120
 Why?
Perception
1
2019
377
0.120
 Why?
Sulfonamides
2
2010
580
0.120
 Why?
Antihypertensive Agents
2
2010
510
0.120
 Why?
Granuloma
1
2016
96
0.120
 Why?
Tidal Volume
1
2016
111
0.120
 Why?
Cyclophosphamide
1
2016
266
0.120
 Why?
Medicare
2
2018
886
0.120
 Why?
Clinical Trials as Topic
3
2024
1053
0.120
 Why?
Muscle Strength
2
2015
330
0.110
 Why?
Health Policy
1
2018
400
0.110
 Why?
Physical Conditioning, Human
1
2015
39
0.110
 Why?
Nitric Oxide
1
2020
897
0.110
 Why?
Neuroendocrine Cells
1
2015
33
0.110
 Why?
Rituximab
1
2016
209
0.110
 Why?
Geographic Information Systems
1
2014
46
0.110
 Why?
Recovery of Function
1
2018
707
0.110
 Why?
Case-Control Studies
4
2019
3604
0.110
 Why?
Enzyme Inhibitors
2
2016
824
0.100
 Why?
Interviews as Topic
2
2016
901
0.100
 Why?
Controlled Clinical Trials as Topic
1
2013
27
0.100
 Why?
Sarcoidosis, Pulmonary
1
2015
95
0.100
 Why?
Societies, Medical
5
2020
887
0.100
 Why?
Sildenafil Citrate
1
2013
60
0.100
 Why?
Information Dissemination
1
2016
223
0.100
 Why?
Carbon Monoxide
3
2019
82
0.100
 Why?
Antifibrinolytic Agents
1
2014
62
0.100
 Why?
Sulfones
1
2013
127
0.100
 Why?
Endpoint Determination
1
2013
83
0.100
 Why?
Phenotype
2
2018
3162
0.100
 Why?
Smoking
3
2019
1472
0.100
 Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2013
42
0.100
 Why?
Predictive Value of Tests
3
2024
2115
0.100
 Why?
Purines
1
2013
187
0.090
 Why?
Practice Guidelines as Topic
1
2020
1560
0.090
 Why?
Patient Dropouts
1
2013
65
0.090
 Why?
Self Report
2
2019
872
0.090
 Why?
Antibiotics, Antineoplastic
1
2013
139
0.090
 Why?
Health Care Surveys
1
2014
539
0.090
 Why?
Pulmonary Gas Exchange
1
2012
119
0.090
 Why?
Histocompatibility Antigens Class II
1
2013
364
0.090
 Why?
Occupational Exposure
1
2016
354
0.090
 Why?
Vasodilator Agents
1
2013
331
0.090
 Why?
Adaptation, Psychological
1
2017
717
0.090
 Why?
Consensus
1
2013
488
0.090
 Why?
Delivery of Health Care
1
2018
947
0.090
 Why?
Minnesota
1
2012
169
0.090
 Why?
Dust
1
2012
102
0.090
 Why?
Piperazines
1
2013
381
0.080
 Why?
United Kingdom
1
2012
338
0.080
 Why?
Fear
1
2014
366
0.080
 Why?
Hydrogen-Ion Concentration
1
2012
561
0.080
 Why?
Epidemiologic Methods
1
2010
89
0.080
 Why?
Clinical Competence
1
2019
1244
0.080
 Why?
Young Adult
5
2017
14105
0.080
 Why?
Health Surveys
1
2012
518
0.080
 Why?
Anti-Infective Agents
1
2013
242
0.080
 Why?
Sickness Impact Profile
2
2009
62
0.080
 Why?
Salivary Glands, Minor
1
2009
10
0.080
 Why?
Pilot Projects
2
2015
1886
0.070
 Why?
Sjogren's Syndrome
1
2009
37
0.070
 Why?
Hyperplasia
2
2015
174
0.070
 Why?
International Cooperation
3
2015
198
0.070
 Why?
Risk
1
2011
911
0.070
 Why?
Scleroderma, Limited
1
2008
5
0.070
 Why?
Europe
3
2015
412
0.070
 Why?
Oximetry
1
2009
126
0.070
 Why?
Poisson Distribution
3
2016
78
0.070
 Why?
Radiography
2
2016
844
0.060
 Why?
Cardiac Catheterization
1
2011
560
0.060
 Why?
Wound Healing
1
2010
351
0.060
 Why?
Comorbidity
2
2017
1658
0.060
 Why?
Sleep Wake Disorders
1
2011
301
0.060
 Why?
Pericardium
1
2007
62
0.060
 Why?
Models, Statistical
1
2011
681
0.060
 Why?
Depression
2
2019
1558
0.060
 Why?
Clinical Trials, Phase III as Topic
2
2016
117
0.060
 Why?
Medical Records
1
2006
187
0.060
 Why?
Seasons
1
2008
556
0.060
 Why?
Regression Analysis
3
2016
1003
0.060
 Why?
Singapore
1
2024
27
0.050
 Why?
California
1
2005
475
0.050
 Why?
Echocardiography
1
2007
652
0.050
 Why?
Bronchoscopy
1
2025
227
0.050
 Why?
Dose-Response Relationship, Drug
2
2020
2027
0.050
 Why?
Acute Disease
1
2006
1030
0.050
 Why?
Data Interpretation, Statistical
2
2018
372
0.050
 Why?
National Institutes of Health (U.S.)
1
2024
140
0.050
 Why?
ROC Curve
1
2025
614
0.050
 Why?
Terminology as Topic
1
2005
255
0.050
 Why?
Lymphoid Tissue
1
2002
80
0.050
 Why?
Rheumatologists
1
2022
15
0.050
 Why?
Exome
1
2023
227
0.040
 Why?
Whole Genome Sequencing
1
2023
182
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2021
77
0.040
 Why?
Age Factors
3
2019
3333
0.040
 Why?
Lysophospholipids
1
2021
77
0.040
 Why?
Patient Care
1
2022
118
0.040
 Why?
Telomere
1
2024
288
0.040
 Why?
Patient Selection
1
2005
719
0.040
 Why?
Attitude
1
2022
260
0.040
 Why?
Total Lung Capacity
1
2019
29
0.040
 Why?
Genomics
1
2025
834
0.040
 Why?
Occupations
1
2019
51
0.040
 Why?
Pulmonary Surfactant-Associated Protein A
1
2019
29
0.040
 Why?
Adolescent
3
2017
22428
0.040
 Why?
Pulmonary Surfactant-Associated Protein C
1
2019
45
0.040
 Why?
GTPase-Activating Proteins
1
2019
82
0.040
 Why?
Disease Models, Animal
1
2010
4557
0.040
 Why?
Blood Gas Analysis
1
2019
83
0.040
 Why?
Exoribonucleases
1
2019
45
0.040
 Why?
ATP-Binding Cassette Transporters
1
2019
118
0.040
 Why?
Administration, Inhalation
1
2020
574
0.030
 Why?
Education
1
2018
104
0.030
 Why?
DNA Helicases
1
2019
143
0.030
 Why?
Telomere-Binding Proteins
1
2019
119
0.030
 Why?
Watchful Waiting
1
2018
89
0.030
 Why?
Administrative Claims, Healthcare
1
2017
28
0.030
 Why?
Physical Endurance
1
2019
278
0.030
 Why?
Forecasting
1
2019
391
0.030
 Why?
Telomerase
1
2019
248
0.030
 Why?
Mucin-5B
1
2019
234
0.030
 Why?
Hypersplenism
1
2016
9
0.030
 Why?
Spirometry
1
2017
231
0.030
 Why?
Leukopenia
1
2016
33
0.030
 Why?
Banking, Personal
1
2016
2
0.030
 Why?
Sequence Analysis, DNA
1
2019
824
0.030
 Why?
Algorithms
1
2024
1837
0.030
 Why?
Rheumatoid Factor
1
2017
175
0.030
 Why?
Health Care Sector
1
2016
26
0.030
 Why?
Creatine Kinase
1
2016
72
0.030
 Why?
Death Certificates
1
2016
32
0.030
 Why?
Social Participation
1
2016
29
0.030
 Why?
High-Throughput Nucleotide Sequencing
1
2019
549
0.030
 Why?
Mass Screening
1
2024
1347
0.030
 Why?
Health Services Needs and Demand
1
2017
280
0.030
 Why?
Arthritis
1
2016
96
0.030
 Why?
Biomarkers
2
2019
4271
0.030
 Why?
Commerce
1
2016
79
0.030
 Why?
Multiple Pulmonary Nodules
1
2015
21
0.030
 Why?
International Classification of Diseases
1
2016
147
0.030
 Why?
Metals
1
2016
142
0.030
 Why?
Anthropometry
1
2015
200
0.030
 Why?
Physical Examination
1
2016
239
0.030
 Why?
Promoter Regions, Genetic
1
2019
1257
0.030
 Why?
Pandemics
1
2023
1694
0.030
 Why?
Genetic Variation
1
2019
983
0.030
 Why?
Disease-Free Survival
1
2016
769
0.030
 Why?
Alberta
1
2013
26
0.030
 Why?
Bronchiolitis
1
2015
87
0.030
 Why?
Mortality, Premature
1
2013
14
0.020
 Why?
Teaching
1
2016
236
0.020
 Why?
Adrenal Cortex Hormones
1
2016
478
0.020
 Why?
Odds Ratio
1
2016
1075
0.020
 Why?
Counseling
1
2016
408
0.020
 Why?
Drug Therapy, Combination
1
2016
1047
0.020
 Why?
RNA
1
2019
940
0.020
 Why?
Genome-Wide Association Study
1
2019
1406
0.020
 Why?
Congresses as Topic
1
2013
221
0.020
 Why?
Administration, Oral
1
2014
847
0.020
 Why?
Antigens, Human Platelet
1
2011
10
0.020
 Why?
Latin America
1
2011
94
0.020
 Why?
Japan
1
2011
143
0.020
 Why?
Genetic Predisposition to Disease
1
2019
2363
0.020
 Why?
Alanine-tRNA Ligase
1
2009
4
0.020
 Why?
Threonine-tRNA Ligase
1
2009
5
0.020
 Why?
Psychiatric Status Rating Scales
1
2011
541
0.020
 Why?
DNA Topoisomerases, Type I
1
2008
16
0.020
 Why?
Syndrome
1
2009
380
0.020
 Why?
Animals
1
2010
38058
0.020
 Why?
Cell Proliferation
1
2015
2496
0.020
 Why?
Lymphocytes
1
2009
382
0.020
 Why?
Pulmonary Wedge Pressure
1
2007
67
0.020
 Why?
Body Mass Index
1
2015
2438
0.020
 Why?
Risk Assessment
1
2015
3671
0.010
 Why?
Muscle, Skeletal
1
2015
1795
0.010
 Why?
Nuclear Proteins
1
2008
748
0.010
 Why?
Child
1
2002
22633
0.010
 Why?
Pneumonia
1
2008
631
0.010
 Why?
Swigris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (372) concept(s)
_
Co-Authors Expand Description
See all (38) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)